A Review on the Role of Neuroplasticity in Neurodegenerative Disorders and Its Possible Pharmacological and Non-Pharmacological Interventions

References (86)

1. 1 The Mesolimbic Dopamine Reward Circuit in Depression [DOI]
2. 2 Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms [DOI]
3. 3 Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action [DOI]
4. 4 Harnessing neuroplasticity for clinical applications [DOI]
5. 5 The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease [DOI]
6. 6 Mitochondria in Neuroplasticity and Neurological Disorders [DOI]
7. 7 The Brain on Stress: Vulnerability and Plasticity of the Prefrontal Cortex over the Life Course [DOI]
8. 8 Activation of the TrkB Neurotrophin Receptor Is Induced by Antidepressant Drugs and Is Required for Antidepressant-Induced Behavioral Effects [DOI]
9. 9 The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression [DOI]
10. 10 The role of oxidative damage and stress in aging [DOI]
11. 11 Neuroscience and education: from research to practice? [DOI]
12. 12 Learning in the Fast Lane: New Insights into Neuroplasticity [DOI]
13. 13 Activation of Necroptosis in Multiple Sclerosis [DOI]
14. 14 Brain plasticity and functional losses in the aged: scientific bases for a novel intervention [DOI]
15. 15 Mitochondria and Neuroplasticity [DOI]
16. 16 The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons [DOI]
17. 17 Neuroplasticity Mediated by Altered Gene Expression [DOI]
18. 18 Why and How Physical Activity Promotes Experience-Induced Brain Plasticity [DOI]
19. 19 Adult Neuroplasticity: More Than 40 Years of Research [DOI]
20. 20 Neuroplastic changes in depression: A role for the immune system [DOI]
21. 21 Dysfunction of NMDA receptors in Alzheimer’s disease [DOI]
22. 22 Nox2-Derived Reactive Oxygen Species Mediate Neurovascular Dysregulation in the Aging Mouse Brain [DOI]
23. 23 Alterations of neuroplasticity in depression: the hippocampus and beyond [DOI]
24. 24 Long-term potentiation and the role of N -methyl- d -aspartate receptors [DOI]
25. 25 The aging process and potential interventions to extend life expectancy.
26. 26 Neuronal Plasticity: Beyond the Critical Period [DOI]
27. 27 A role for tau at the synapse in Alzheimer's disease pathogenesis [DOI]
28. 28 Neuroscience in the Public Sphere [DOI]
29. 29 Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder [DOI]
30. 30 Neuroplasticity in Alzheimer's disease [DOI]
31. 31 Roles of mTOR Signaling in Brain Development [DOI]
32. 32 The Role of BDNF as a Mediator of Neuroplasticity in Bipolar Disorder [DOI]
33. 33 Immune changes and neurotransmitters: Possible interactions in depression? [DOI]
34. 34 Neuroplasticity in response to cognitive behavior therapy for social anxiety disorder [DOI]
35. 35 Alzheimer disease pathology in cognitively healthy elderly: A genome-wide study [DOI]
36. 36 Brain Imaging Techniques and Their Applications in Decision-Making Research [DOI]
37. 37 Scales For Measuring Depression and Anxiety [DOI]
38. 38 Etiological paradigms of depression: The relationship between perceived causes, empowerment, treatment preferences, and stigma [DOI]
39. 39 The dark side of neuroplasticity [DOI]
40. 40 Reduction of Cerebral Oxidative Stress Following Environmental Enrichment in Mice with Alzheimer‐Like Pathology [DOI]
41. 41 Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia [DOI]
42. 42 Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain.
43. 43 Epigenetic Mechanisms in Alzheimer's Disease [DOI]
44. 44 Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome [DOI]
45. 45 Neuroplasticity and Brain Imaging Research: Implications for Rehabilitation [DOI]
46. 46 Pharmacological Treatment of Sleep Disorders and Its Relationship with Neuroplasticity [DOI]
47. 47 Neuroplasticity: An Appreciation From Synapse to System [DOI]
48. 48 Neurogenesis in the Adult Hippocampus [DOI]
49. 49 BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity [DOI]
50. 50 Sleep, insomnia, and depression [DOI]
51. 51 Human Adult Neurogenesis: Evidence and Remaining Questions [DOI]
52. 52 Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model [DOI]
53. 53 Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons [DOI]
54. 54 Running-Induced Systemic Cathepsin B Secretion Is Associated with Memory Function [DOI]
55. 55 Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases [DOI]
56. 56 The aging mind: neuroplasticity in response to cognitive training [DOI]
57. 57 NAD + in Aging: Molecular Mechanisms and Translational Implications [DOI]
58. 58 Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling [DOI]
59. 59 The Impact of Studying Brain Plasticity [DOI]
60. 60 Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance [DOI]
61. 61 From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder [DOI]
62. 62 Biological hypotheses and biomarkers of bipolar disorder [DOI]
63. 63 An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms [DOI]
64. 64 Apoptotic cell death regulation in neurons [DOI]
65. 65 Oxidative Stress in Hypoxic-Ischemic Encephalopathy: Molecular Mechanisms and Therapeutic Strategies [DOI]
66. 66 Necroptosis in neurodegenerative diseases: a potential therapeutic target [DOI]
67. 67 Molecular and cellular pathways contributing to brain aging [DOI]
68. 68 Molecular mechanisms of neuroplasticity: An expanding universe [DOI]
69. 69 Environmental enrichment increases transcriptional and epigenetic differentiation between mouse dorsal and ventral dentate gyrus [DOI]
70. 70 Mitochondria and Inflammation: Cell Death Heats Up [DOI]
71. 71 Beyond Cell Death: New Functions for TNF Family Cytokines in Autoimmunity and Tumor Immunotherapy [DOI]
72. 72 Physical Activity Modulates Common Neuroplasticity Substrates in Major Depressive and Bipolar Disorder [DOI]
73. 73 Pathophysiology of Insomnia [DOI]
74. 74 Neuropathological approaches to cerebral aging and neuroplasticity [DOI]
75. 75 Neuroplasticity in mood disorders [DOI]
76. 76 Harnessing neuroplasticity: modern approaches and clinical future [DOI]
77. 77 Lifestyle Shapes the Dialogue between Environment, Microglia, and Adult Neurogenesis [DOI]
78. 78 Role of Lifestyle in Neuroplasticity and Neurogenesis in an Aging Brain [DOI]
79. 79 Common cellular and molecular mechanisms and interactions between microglial activation and aberrant neuroplasticity in depression [DOI]
80. 80 Neuroplasticity Improves Bipolar Disorder: A Review [DOI]
81. 81 Neuroplasticity in Brain Injury: Maximizing Recovery [DOI]
82. 82 Functional Neuroplasticity of Adults with Partial or Complete Denture Rehabilitation with or without Implants: Evidence from fMRI Studies [DOI]
83. 83 EDUCATION AND DEMENTIA: WHAT LIES BEHIND THE ASSOCIATION? [DOI]
84. 84 The Roles of T Cells in Clinical Depression [DOI]
85. 85 Adult neuroplasticity: A new “cure” for major depression? [DOI]
86. 86 Aging and neuroplasticity [DOI]

Cited by 0

No indexed citations yet.

Related research

• Perceived Stress and Anxiety in Women during Labour: A Case of Tamale West Hospital, Tamale, Ghana — shares topic coverage
• Anxiety and Visual Field Assessment Reliability in Glaucoma Patients — shares topic coverage
• Effect of Crude Ethanol Leaf-extract of Murraya koenigii on Anxiety in Mice — shares topic coverage
• Antiretroviral Therapy may have Anxiogenic Effect on Subjects — shares topic coverage
• The Prevalence of Irritable Bowel Syndrome (IBS) in a Private-University in Malaysia, and Its Associated Factors Including Stress, Depression and Anxiety — shares topic coverage